US 5,789,156 Β· Granted 1998-08-04

Tetracycline-regulated transcriptional inhibitors

Nucleic acid molecules and proteins useful for regulating the expression of genes in eukaryotic cells and organisms in a highly controlled manner are disclosed. In the regulatory system of the invention, transcription of a tet operator-linked nucleotide sequence is inhibited by a transcriptional inhibitor fusion protein composed of two polypeptides, a first polypeptide which binds to tet operator sequences either (i) in the absence but not the presence of tetracycline (or an analogue thereof) or (ii) in the presence but not the absence of tetracycline (or an analogue thereof), and a second polypeptide which directly or indirectly inhibits transcription in eukaryotic cells. In one embodiment, the fusion protein comprises a Tet repressor operatively linked to a transcriptional silencer polypeptide. In another embodiment, the fusion protein comprises a mutated Tet repressor operatively linked to a transcriptional silencer polypeptide. The fusion proteins of the invention are useful for reducing the level of transcription of a tet operator-linked target gene. Moreover, the fusion proteins of the invention can be used in combination with tetracycline-regulated transcriptional activator fusion proteins to allow for precise regulation of the expression of one or multiple target genes. Kits including the components of the regulatory system of the invention are also encompassed by the invention.

Patent details

Publication number
US 5,789,156
Filing date
1995-02-03
Grant date
1998-08-04
Assignee
Basf Ag / Knoll Ag
Inventor(s)
BUJARD; HERMANN, GOSSEN; MANFRED
CPC class
C12N15/8509

Want to file your own patent?

Run your idea through our free scanner β€” we’ll show you which existing patents are conceptually closest, including this one if it’s a match.

Free patentability scan